{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:56:18Z","timestamp":1774317378988,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2013CB932500"],"award-info":[{"award-number":["2013CB932500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690263"],"award-info":[{"award-number":["81690263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773657"],"award-info":[{"award-number":["81773657"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2017-01-07-00-07E00052"],"award-info":[{"award-number":["2017-01-07-00-07E00052"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.apsb.2020.07.024","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T02:40:50Z","timestamp":1597286450000},"page":"283-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated"],"prefix":"10.1016","volume":"11","author":[{"given":"Jinyang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.07.024_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.apsb.2020.07.024_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2020.07.024_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.07.024_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1179\/016164105X39833","article-title":"Expression of VEGF and its receptors in different brain tumors","volume":"27","author":"Huang","year":"2005","journal-title":"Neurol Res"},{"key":"10.1016\/j.apsb.2020.07.024_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/B:NEON.0000021737.89357.cc","article-title":"Functional significance of vascular endothelial growth factor receptor expression on human glioma cells","volume":"67","author":"Mentlein","year":"2004","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.apsb.2020.07.024_bib6","doi-asserted-by":"crossref","first-page":"22191","DOI":"10.18632\/oncotarget.4339","article-title":"Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response","volume":"6","author":"Smith","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2020.07.024_bib7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1158\/0008-5472.CAN-10-2700","article-title":"E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models","volume":"71","author":"Bello","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2020.07.024_bib8","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1111\/j.1582-4934.2012.01541.x","article-title":"AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR","volume":"16","author":"Zhou","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.apsb.2020.07.024_bib9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0002-9440(10)65668-4","article-title":"Host microvasculature influence on tumor vascular morphology and endothelial gene expression","volume":"153","author":"Roberts","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2020.07.024_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0022-510X(72)90019-6","article-title":"Microvascular abnormalities in virally-induced canine brain tumors: structural bases for altered blood\u2013brain barrier function","volume":"17","author":"Vick","year":"1972","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.apsb.2020.07.024_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2009.12.020","article-title":"Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect","volume":"143","author":"Zhan","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.07.024_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.apsb.2017.07.002","article-title":"Remodeling the blood\u2013brain barrier microenvironment by natural products for brain tumor therapy","volume":"7","author":"Zhao","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.07.024_bib13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00109-019-01843-4","article-title":"Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid\u2013PLGA nanoparticles improves EGFR-targeted therapy for glioma","volume":"97","author":"Ye","year":"2019","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.apsb.2020.07.024_bib14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/1568009616666161227091522","article-title":"A rational approach to target the epidermal growth factor receptor in glioblastoma","volume":"17","author":"Kwatra","year":"2017","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.apsb.2020.07.024_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","article-title":"Transport of drugs across the blood\u2013brain barrier by nanoparticles","volume":"161","author":"Wohlfart","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.07.024_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.07.024_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.apsb.2018.10.005","article-title":"Emerging transporter-targeted nanoparticulate drug delivery systems","volume":"9","author":"Su","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.07.024_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.apsb.2020.07.024_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jconrel.2019.11.005","article-title":"Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes","volume":"316","author":"Wang","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.07.024_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2018.12.003","article-title":"Liposomes with cyclic RGD peptide motif triggers acute immune response in mice","volume":"293","author":"Wang","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.07.024_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jconrel.2020.04.009","article-title":"\u03b1v\u03b23-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy","volume":"322","author":"Li","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.07.024_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jgm.2726","article-title":"Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery","volume":"15","author":"Lei","year":"2013","journal-title":"J Gene Med"},{"key":"10.1016\/j.apsb.2020.07.024_bib23","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41467-018-05384-1","article-title":"Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption","volume":"9","author":"Guan","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2020.07.024_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2015.09.059","article-title":"Liposome-based glioma targeted drug delivery enabled by stable peptide ligands","volume":"218","author":"Wei","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.07.024_bib25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/aps.2017.107","article-title":"Evaluation of in\u00a0vitro and in\u00a0vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer","volume":"38","author":"Xie","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2020.07.024_bib26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2016.05.047","article-title":"Pathways of immediate hypothermia and leukocyte infiltration in an adjuvant-free mouse model of anaphylaxis","volume":"139","author":"Balbino","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.apsb.2020.07.024_bib27","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1039\/C5SM01455G","article-title":"Nanoparticle stability in biologically relevant media: Influence of polymer architecture","volume":"11","author":"Aguilar-Castillo","year":"2015","journal-title":"Soft Matter"},{"key":"10.1016\/j.apsb.2020.07.024_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08982100802309552","article-title":"Liposome-mediated triggering of complement cascade","volume":"18","author":"Moghimi","year":"2008","journal-title":"J Liposome Res"},{"key":"10.1016\/j.apsb.2020.07.024_bib29","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1021\/acsnano.6b00261","article-title":"Exploring cellular interactions of liposomes using protein corona fingerprints and physicochemical properties","volume":"10","author":"Bigdeli","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2020.07.024_bib30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in\u00a0vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2020.07.024_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2010.08.026","article-title":"Peritoneal retention of liposomes: effects of lipid composition, PEG coating and liposome charge","volume":"148","author":"Dadashzadeh","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.07.024_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2020.07.024_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1081\/LPR-64971","article-title":"Liposome opsonization","volume":"15","author":"Yan","year":"2005","journal-title":"J Liposome Res"},{"key":"10.1016\/j.apsb.2020.07.024_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.it.2004.04.008","article-title":"Structure and activation of the C1 complex of complement: unraveling the puzzle","volume":"25","author":"Gaboriaud","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2020.07.024_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(97)00133-6","article-title":"Receptor versus non-receptor mediated clearance of liposomes","volume":"32","author":"Scherphof","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2020.07.024_bib36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/08923970902845768","article-title":"The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1\/CD35)","volume":"31","author":"Liu","year":"2009","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.apsb.2020.07.024_bib37","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbrc.2004.10.104","article-title":"A role for scavenger receptor B-I in selective transfer of rhodamine-PE from liposomes to cells","volume":"325","author":"Yan","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.07.024_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0163-7827(00)00020-5","article-title":"The role of hepatocytes in the clearance of liposomes from the blood circulation","volume":"40","author":"Scherphof","year":"2001","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2020.07.024_bib39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2011.07.034","article-title":"LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor","volume":"157","author":"Yan","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.07.024_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nnano.2009.175","article-title":"Evaluation of nanoparticle immunotoxicity","volume":"4","author":"Dobrovolskaia","year":"2009","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2020.07.024_bib41","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.33549\/physiolres.933526","article-title":"Athymic nude mice as an experimental model for cancer treatment","volume":"65","author":"Szadvari","year":"2016","journal-title":"Physiol Res"},{"key":"10.1016\/j.apsb.2020.07.024_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-3083.1980.tb00063.x","article-title":"Change in the humoral response of athymic nude mice with ageing","volume":"12","author":"Piguet","year":"1980","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.apsb.2020.07.024_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.immuni.2008.02.008","article-title":"Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis","volume":"28","author":"Tsujimura","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2020.07.024_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cellimm.2014.03.018","article-title":"Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB\/c and C57BL\/6 mice","volume":"289","author":"Jiao","year":"2014","journal-title":"Cell Immunol"},{"key":"10.1016\/j.apsb.2020.07.024_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.18176\/jiaci.0046","article-title":"Mechanisms of anaphylaxis beyond IgE","volume":"26","author":"Munoz-Cano","year":"2016","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.apsb.2020.07.024_bib46","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2020.07.024_bib47","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22034","article-title":"Liver: an organ with predominant innate immunity","volume":"47","author":"Gao","year":"2008","journal-title":"Hepatology"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520306699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520306699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:45:14Z","timestamp":1761929114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383520306699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2211383520306699"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.07.024","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}